1 active not recruiting, 1 completed, 1 temporarily not available. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Acellular Tissue Engineered Vessel (ATEV): new trials by email Literature Review of Acellular Tissue Engineered Vessel (ATEV) trials Research Report on Acellular Tissue Engineered Vessel (ATEV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis Acellular Tissue Engineered Vessel (ATEV), AVF - End Stage Renal Disease (ESRD) | Phase 3 | Active not recruiting | Humacyte, Inc. | 121 | 2023-09-07 | 2026-06-26 |
| Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma Acellular Tissue Engineered Vessel (ATEV) - Trauma, Vascular System Injury | Phase 2 / Phase 3 | Completed | Humacyte, Inc. | 72 | 2018-09-01 | 2026-07-29 |
| Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access Acellular Tissue Engineered Vessel (ATEV) - Vascular Diseases, End Stage Renal Disease on Dialysis | Temporarily not available | Humacyte, Inc. | 2026-09-15 |
Kidney Failure, Chronic (1) · Vascular Diseases (1) · Vascular System Injuries (1) · Wounds and Injuries (1)
Humacyte, Inc. (3)
United States (2) · Israel (1)